Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
Ophthalmic Research
|
May 28, 2016
Safety and Efficacy of Autologous Plasma Rich in Growth Factors Eye Drops for the Treatment of Evaporative Dry Eye
Jesús Merayo-Lloves, Ronald M Sanchez-Avila, Ana C Riestra, et al.
Immunotherapy
|
January 7, 2020
Safety evaluation of a multiallergen immunotherapy treatment in polyallergic patients. APOLO observational study
Pilar Alba, Victoria Moreno, José Arias-Irigoyen, et al.
International Ophthalmology
|
June 17, 2017
Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops
Ronald Mauricio Sanchez-Avila, Jesus Merayo-Lloves, Ana Cristina Riestra, et al.
Immunotherapy
|
June 26, 2019
Tolerability and surrogate efficacy parameters of a polymerized depot mixture pollen extracts without dilutional effect
Joaquín Quiralte, María Angeles Lara, Gemma Vanesa Sánchez, et al.
Expert Review of Clinical Immunology
|
June 27, 2024
Efficacy and safety of subcutaneous immunotherapy with polymerized allergen mixtures in polyallergic patients - ARES observational study
Marcela Santaolalla, José Arias-Irigoyen, Jose Miguel Soler, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
Ophthalmic Research
|
May 28, 2016
Safety and Efficacy of Autologous Plasma Rich in Growth Factors Eye Drops for the Treatment of Evaporative Dry Eye
Jesús Merayo-Lloves, Ronald M Sanchez-Avila, Ana C Riestra, et al.
Immunotherapy
|
January 7, 2020
Safety evaluation of a multiallergen immunotherapy treatment in polyallergic patients. APOLO observational study
Pilar Alba, Victoria Moreno, José Arias-Irigoyen, et al.
International Ophthalmology
|
June 17, 2017
Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops
Ronald Mauricio Sanchez-Avila, Jesus Merayo-Lloves, Ana Cristina Riestra, et al.
Immunotherapy
|
June 26, 2019
Tolerability and surrogate efficacy parameters of a polymerized depot mixture pollen extracts without dilutional effect
Joaquín Quiralte, María Angeles Lara, Gemma Vanesa Sánchez, et al.
Expert Review of Clinical Immunology
|
June 27, 2024
Efficacy and safety of subcutaneous immunotherapy with polymerized allergen mixtures in polyallergic patients - ARES observational study
Marcela Santaolalla, José Arias-Irigoyen, Jose Miguel Soler, et al.
Page
of 2